On May 31, 2022, Oncocross Co., Ltd. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,800 KRW | -10.00% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 7.18M | |
-10.04% | 1.11B | |
+39.05% | 962M | |
-0.90% | 498M | |
-14.20% | 416M | |
-26.02% | 338M | |
-1.31% | 337M | |
-33.53% | 302M | |
-0.26% | 276M | |
-12.01% | 90.74M |
- Stock Market
- Equities
- A299670 Stock
- News SM VINA Co., Ltd.
- Oncocross Co., Ltd. announced that it has received KRW 1.600015235 billion in funding from SM VINA Co., Ltd., C&M Trading Co., Ltd., DB Korea Discovery Co., Ltd.